procaterol 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| bronchodilators, phenethylamine derivatives | 2273 | 72332-33-3 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
A long-acting beta-2-adrenergic receptor agonist.
|
Drug dosage:
| Dose | Unit | Route |
|---|---|---|
| 60 | mcg | Inhal.aerosol |
| 0.10 | mg | O |
ADMET properties:
| Property | Value | Reference |
|---|---|---|
| BA (Bioavailability) | 40 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
Approvals:
None
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | R03AC16 | RESPIRATORY SYSTEM DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES ADRENERGICS, INHALANTS Selective beta-2-adrenoreceptor agonists |
| ATC | R03CC08 | RESPIRATORY SYSTEM DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES ADRENERGICS FOR SYSTEMIC USE Selective beta-2-adrenoreceptor agonists |
| MeSH PA | D018663 | Adrenergic Agents |
| MeSH PA | D000322 | Adrenergic Agonists |
| MeSH PA | D058666 | Adrenergic beta-2 Receptor Agonists |
| MeSH PA | D000318 | Adrenergic beta-Agonists |
| MeSH PA | D018927 | Anti-Asthmatic Agents |
| MeSH PA | D001993 | Bronchodilator Agents |
| MeSH PA | D018377 | Neurotransmitter Agents |
| MeSH PA | D018373 | Peripheral Nervous System Agents |
| MeSH PA | D019141 | Respiratory System Agents |
| MeSH PA | D013566 | Sympathomimetics |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 10.58 | acidic |
| pKa2 | 11.26 | acidic |
| pKa3 | 9.7 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Beta-2 adrenergic receptor | GPCR | AGONIST | EC50 | 8.43 | IUPHAR | IUPHAR | |||
| D(2) dopamine receptor | GPCR | Ki | 4.07 | CHEMBL |
External reference:
| ID | Source |
|---|---|
| N0000166917 | NUI |
| D08424 | KEGG_DRUG |
| C0072032 | UMLSCUI |
| CHEBI:135209 | CHEBI |
| CHEMBL160519 | ChEMBL_ID |
| DB01366 | DRUGBANK_ID |
| D017265 | MESH_DESCRIPTOR_UI |
| 4916 | PUBCHEM_CID |
| 3464 | IUPHAR_LIGAND_ID |
| 4259 | INN_ID |
| X7I3EMM5K0 | UNII |
| 34530 | RXNORM |
| 003878 | NDDF |
| 703566006 | SNOMEDCT_US |
Pharmaceutical products:
None